Diversion Quarterly Q1 2021

Kit Check is sharing data from its Bluesight™ for Controlled Substances platform on a quarterly basis to provide insight into the types of diversions and investigations that may be occurring in hospital pharmacies. The following information is as of March 31, 2021. Data was pulled from health systems across the United States.

Commentary from the CEO

“Reviewing and resolving documentation variances is extremely valuable and important, and this wouldn’t be possible without the ability for 100% audit of cases,” said Kevin MacDonald, CEO of Kit Check. “We’ve seen an overall 17% increase in hospitals using investigations and a 35% increase in investigations per hospital from last quarter. With the distribution of the COVID-19 vaccination underway, the pandemic continues to take a toll on healthcare facilities. We continue to see an increase in drug diversion, so it’s important that healthcare providers find a balance between providing quality patient care and managing day-to-day activities.”

Download the latest information about our suite of medication intelligence products by using the button below.